Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

The Relationship between the Serum Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Pulse Pressure in Korean Adults with Hypertension

대한민국 고혈압 성인에서 아스파르트산 아미노전이효소/알라닌 아미노전이효소 비율과 맥압의 관련성

  • Yoon, Hyun (Department of Clinical Laboratory Science, Wonkwang Health Science University)
  • 윤현 (원광보건대학교 임상병리과)
  • Received : 2021.06.28
  • Accepted : 2021.07.23
  • Published : 2021.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was conducted to assess the relationship between aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio and pulse pressure in Korean adults with hypertension. Data from 1,515 adults from the sixth Korean National Health and Nutrition Examination Survey (KNHANES VI-3, 2015) were analyzed. There were several key findings in the present study. First, aspartate aminotransferase (odds ratio [OR], 1.018; 95% confidence interval [CI], 1.002 to 1.033), alanine aminotransferase (OR, 0.982; 95% CI, 0.969 to 0.996), and aspartate aminotransferase/alanine aminotransferase ratio (OR, 1.367; 95% CI, 1.027 to 1.819) were the independent factors determining high pulse pressure. Second, after adjusting for related variables [age, gender, smoking, alcohol consumption, regular exercise, total cholesterol (TC), triglycerides (TGs), high-density lipoprotein-cholesterol (HDL-C), fasting plasma glucose (FPG), body mass index (BMI), and waist circumference (WC)], the ORs of high pulse pressure with the 1st quartile as a reference were significantly higher in the 4th quartile of aspartate aminotransferase/alanine aminotransferase ratio [1.632 (95% CI, 1.113~2.393)]. The high pulse pressure was positively associated with aspartate aminotransferase and alanine aminotransferase/alanine aminotransferase ratio in Korean adults with hypertension, but was inversely associated with alanine aminotransferase.

본 연구는 고혈압이 있는 대한민국 성인에서 아스파르트산 아미노전이효소(aspartate aminotransferase, AST)/알라닌 아미노전이효소(alanine aminotransferase, ALT) 비율과 맥압(pulse pressure, PP) 사이의 관계를 평가하기 위해 수행되었다. 제6차 국민건강영양조사(KNHANES VI-3, 2015)에서 성인 1,515명의 데이터를 분석했다. 본 연구에서는 몇 가지 중요한 결과가 있다. 첫째, AST (odds ratio [OR], 1.018; 95% confidence interval [CI], 1.002~1.033), ALT (OR, 0.982; 95% CI, 0.969~0.996) 및 AST/ALT ratio (OR, 1.367; 95% CI, 1.027~1.819)는 고PP 결정하는 독립적인 요인이었다. 둘째, 관련변수(연령, 성별, 흡연, 음주, 규칙적인 운동, TC, TG, HDL-C, FBG, BMI, WC)를 조정한 후의 결과에서 AST/ALT ratio의 1 사분위에 대한 고PP의 OR을 기준으로, AST/ALT ratio의 2 사분위(OR, 1.188; 95% CI, 0.817~1.727) 및 AST/ALT ratio의 3 사분위(OR, 1.169; 95% CI, 0.800~1.710)는 유의하지 않았지만, AST/ALT ratio의 4 사분위(OR, 1.632, 95% CI, 1.113~2.393)에서 유의하게 높았다. 결론적으로, 고혈압이 있는 대한민국 성인에서 고PP은 AST/ALT ratio 및 AST와 양의 상관관계가 있었지만 ALT와 음의 상관계가 있었다.

Keywords

Acknowledgement

This paper was supported by Wonkwang Health Science University in 2021.

References

  1. Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol. 2001;88:980-986. https://doi.org/10.1016/s0002-9149(01)01974-9
  2. Zhao L, Song Y, Dong P, Li Z, Yang X, Wang S. Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: a meta-analysis of prospective observational studies. J Clin Hypertens (Greenwich). 2014;16:678-685. https://doi.org/10.1111/jch.12375
  3. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032-1037. https://doi.org/10.1016/j.jacc.2009.09.061
  4. Mazza A, Pessina AC, Gianluca P, Tikhonoff V, Pavei A, Casiglia E. Pulse pressure: an independent predictor of coronary and stroke mortality in elderly females from the general population. Blood Press. 2001;10:205-211. https://doi.org/10.1080/08037050152669710
  5. Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med. 2000;107:100-102,105-109,113-114. https://doi.org/10.3810/pgm.2000.02.869
  6. Nyblom H, Bjornsson E, Simren M, Aldenborg F, Almer S, Olsson R. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int. 2006;26:840-845. https://doi.org/10.1111/j.1478-3231.2006.01304.x
  7. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis-epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122:129-139. https://doi.org/10.1007/s00508-010-1357-6
  8. Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804-2811. https://doi.org/10.1093/eurheartj/eht246
  9. Glinghammar B, Rafter I, Lindstrom AK, Hedberg JJ, Andersson HB, Lindblom P, et al. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int J Mol Med. 2009;23:621-631. https://doi.org/10.3892/ijmm_00000173
  10. Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore). 2016;95:e4821. https://doi.org/10.1097/MD.0000000000004821
  11. Yokoyama M, Watanabe T, Otaki Y, Takahashi H, Arimoto T, Shishido T, et al. Association of the aspartate aminotransferase to alanine aminotransferase ratio with BNP level and cardiovascular mortality in the general population: the yamagata study 10-year follow-up. Dis Markers. 2016;2016:4857917. https://doi.org/10.1155/2016/4857917
  12. Su TC, Chien KL, Jeng JS, Chang CJ, Hsu HC, Chen MF, et al. Pulse pressure, aortic regurgitation and carotid atherosclerosis: a comparison between hypertensives and normotensives. Int J Clin Pract. 2006;60:134-140. https://doi.org/10.1111/j.1742-1241.2006.00777.x
  13. Mancusi C, Losi MA, Izzo R, Canciello G, Carlino MV, Albano G, et al. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: the campania salute network. Eur J Prev Cardiol. 2018;25:235-243. https://doi.org/10.1177/2047487317747498
  14. Yoon H. Association between pulse pressure and impaired pulmonary function in non-smoking adults. Korean J Clin Lab Sci. 2020;52:119-127. https://doi.org/10.15324/kjcls.2020.52.2.119
  15. Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, et al. Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C-a cross-sectional study. Vasc Health Risk Manag. 2014;10:55-62. https://doi.org/10.2147/VHRM.S53557
  16. Ostovaneh MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, Shah R, Murthy VL, et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circ Cardiovasc Imaging. 2018;11:e007241. https://doi.org/10.1161/CIRCIMAGING.117.007241
  17. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44-48. https://doi.org/10.1111/j.1572-0241.1998.044_c.x
  18. Botros M, Sikaris KA. The de ritis ratio: the test of time. Clin Biochem Rev. 2013;34:117-130.
  19. Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore). 2016;95:e4821. https://doi.org/10.1097/MD.0000000000004821
  20. Vonbank A, Saely C, Rein P, Zanolin D, Leiherer A, Drexel H. The alanine aminotransferase/aspartate aminotransferase ratio predicts future cardiovascular events in patients with established coronary artery disease and homa insulin resistance. Atherosclerosis. 2016;252:e64-65. https://doi.org/10.1016/j.atherosclerosis.2016.07.445
  21. Rief P, Pichler M, Raggam R, Hafner F, Gerger A, Eller P, et al. The AST/ALT (De-Ritis) ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. Medicine (Baltimore). 2016;95:e3843. https://doi.org/10.1097/MD.0000000000003843
  22. Dart AM, Kingwell BA. Pulse pressure--a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37:975-984. https://doi.org/10.1016/s0735-1097(01)01108-1
  23. Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension. 2005;45:586-591. https://doi.org/10.1161/01.HYP.0000158843.60830.cf
  24. Fagard RH, Pardaens K, Staessen JA, Thijs L. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol. 2001; 38:227-231. https://doi.org/10.1016/s0735-1097(01)01362-6
  25. Rizzo V, di Maio F, Petretto F, Marziali M, Bianco G, Barilla F, et al. Ambulatory pulse pressure, left ventricular hypertrophy and function in arterial hypertension. Echocardiography. 2004; 21:11-16. https://doi.org/10.1111/j.0742-2822.2004.02146.x
  26. White WB. Systolic versus diastolic blood pressure versus pulse pressure. Curr Cardiol Rep. 2002;4:463-467. https://doi.org/10.1007/s11886-002-0107-4
  27. Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8:6366. https://doi.org/10.1038/s41598-018-24875-1
  28. Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60:347-353. https://doi.org/10.1161/HYPERTENSIONAHA.112.195032
  29. Kucukseymen S, Cekin AH, Bayar N, Arslan S, Uygur Kucukseymen E, Mercan T, et al. A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease. PLoS One. 2018;13:e0190382. https://doi.org/10.1371/journal.pone.0190382
  30. Mantovani A, Zoppini G, Targher G, Golia G, Bonora E. Nonalcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals. J Endocrinol Invest. 2012;35:215-218. https://doi.org/10.1007/BF03345421
  31. Chen Y, Xu M, Wang T, Sun J, Sun W, Xu B, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015;241:145-150. https://doi.org/10.1016/j.atherosclerosis.2015.05.002
  32. Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with nonalcoholic fatty liver disease. J Hepatol. 2013;58:757-762. https://doi.org/10.1016/j.jhep.2012.11.015
  33. Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The association between non-invasive hepatic fibrosis markers and cardiometabolic risk factors in the framingham heart study. PLoS One. 2016;11:e0157517. https://doi.org/10.1371/journal.pone.0157517
  34. Abbas G, Silveira MG, Lindor KD. Hepatic fibrosis and the renin-angiotensin system. Am J Ther. 2011;18:e202-208. https://doi.org/10.1097/MJT.0b013e3181df8df5
  35. Kim G, Kim J, Lim YL, Kim MY, Baik SK. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review. Hepatol Int. 2016;10:819-828. https://doi.org/10.1007/s12072-016-9705-x
  36. Neves MF, Cunha AR, Cunha MR, Gismondi RA, Oigman W. The role of renin-angiotensin-aldosterone system and its new components in arterial stiffness and vascular aging. High Blood Press Cardiovasc Prev. 2018;25:137-145. https://doi.org/10.1007/s40292-018-0252-5
  37. Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res. 2003;26:609-614. https://doi.org/10.1291/hypres.26.609